CRANIAL MRI IN WILSONS-DISEASE

被引:123
作者
PRAYER, L
WIMBERGER, D
KRAMER, J
GRIMM, G
ODER, W
IMHOF, H
机构
[1] UNIV VIENNA, LUDWIG BOLTZMANN INST RADIOPHYS TUMORDIAG, A-1090 VIENNA, AUSTRIA
[2] UNIV VIENNA, DEPT NEUROL, A-1010 VIENNA, AUSTRIA
[3] UNIV VIENNA, DEPT MED 1, A-1010 VIENNA, AUSTRIA
关键词
D-penicillamine; Duration of disease; MRI; Neurologic symptoms; Wilson's disease;
D O I
10.1007/BF00589114
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Thirty-eight patients with biochemically proven Wilson's disease underwent magnetic resonanceimaging (MRI) of the brain as well as neurological examinations. The patients were scanned using spin-echo (SE) sequences; the neurologist was looking for typical symptoms: dysarthria, tremor, ataxia, rigidity/bradykinesia and chorea/dystonia. Pathological MR findings believed secondary to this uncommon inherited disorder of copper metabolism were found in twenty-two subjects. Focal abnormalities were seen in the lenticular, thalamic and caudate nuclei as well as in brain stem and white matter; these lesions were best demonstrated on T2-weighted sequences as hyperintense areas. In eight patients we found diffuse brain atrophy with consecutive widening of the ventricular system. Five subjects showed mild, nineteen severe neurologic deficits. Generally there was no correlation between MR findings and clinical neurological symptoms; the impairment of cell-metabolism causing functional alterations of the brain precedes morphological changes. During treatment with the copper chelator D-penicillamine there seemed to be a phased course of disease. Shortening of T1-relaxation due to paramagnetic influence of copper was not seen; a possible explanation could be intracellular deposition - a proton-electron-dipolar-dipolar-interaction would therefor be impossible. © 1990 Springer-Verlag.
引用
收藏
页码:211 / 214
页数:4
相关论文
共 14 条
[1]   WILSON DISEASE OF THE BRAIN - MR IMAGING [J].
AISEN, AM ;
MARTEL, W ;
GABRIELSEN, TO ;
GLAZER, GM ;
BREWER, G ;
YOUNG, AB ;
HILL, G .
RADIOLOGY, 1985, 157 (01) :137-141
[2]   HIGH-FIELD MAGNETIC-RESONANCE-IMAGING OF WILSONS-DISEASE [J].
DEHAAN, J ;
GROSSMAN, RI ;
CIVITELLO, L ;
HACKNEY, DB ;
GOLDBERG, HI ;
BILANIUK, LT ;
ZIMMERMAN, RA .
CT-JOURNAL OF COMPUTED TOMOGRAPHY, 1987, 11 (02) :132-135
[3]   EFFECT OF D-PENICILLAMINE TREATMENT ON BRAIN METABOLISM IN WILSONS-DISEASE - A CASE-STUDY [J].
DEVOLDER, A ;
SINDIC, CJM ;
GOFFINET, AM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1988, 51 (07) :947-949
[4]   MRI IN WILSONS-DISEASE - TISSUE DIFFERENTIATION OF DEGENERATIVE INTRACEREBRAL CHANGES [J].
DORNEMANN, H ;
PETSCH, R ;
BRAITINGER, S .
FORTSCHRITTE AUF DEM GEBIETE DER RONTGENSTRAHLEN UND DER NUKLEARMEDIZIN, 1987, 147 (05) :570-571
[5]  
GREENFIELD JG, 1984, GREENFIELDS NEUROPAT
[6]   WILSONS-DISEASE STUDIED WITH FDG AND POSITRON EMISSION TOMOGRAPHY [J].
HAWKINS, RA ;
MAZZIOTTA, JC ;
PHELPS, ME .
NEUROLOGY, 1987, 37 (11) :1707-1711
[7]   NUCLEAR MAGNETIC-RESONANCE (NMR) IMAGING IN WILSON DISEASE [J].
LAWLER, GA ;
PENNOCK, JM ;
STEINER, RE ;
JENKINS, WJ ;
SHERLOCK, S ;
YOUNG, IR .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1983, 7 (01) :1-8
[8]  
NADJMI MR, 1981, KRANIELLE COMPUTER T
[9]  
NIX WA, 1984, NERVENARZT, V55, P544
[10]   WILSONS-DISEASE - EVOKED-POTENTIALS AND COMPUTED-TOMOGRAPHY [J].
ROACH, ES ;
FORD, CS ;
SPUDIS, EV ;
RIELA, AR ;
MCLEAN, WT ;
GILLIAM, J ;
BALL, MR .
JOURNAL OF NEUROLOGY, 1985, 232 (01) :20-23